Raia Drogasil Statistics
Total Valuation
Raia Drogasil has a market cap or net worth of 4.59 billion. The enterprise value is 5.87 billion.
Market Cap | 4.59B |
Enterprise Value | 5.87B |
Important Dates
The last earnings date was Tuesday, May 6, 2025.
Earnings Date | May 6, 2025 |
Ex-Dividend Date | May 1, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -1.63% |
Shares Change (QoQ) | +0.30% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 856.18M |
Valuation Ratios
The trailing PE ratio is 22.42 and the forward PE ratio is 23.55.
PE Ratio | 22.42 |
Forward PE | 23.55 |
PS Ratio | 0.66 |
PB Ratio | 4.05 |
P/TBV Ratio | 5.89 |
P/FCF Ratio | 20.25 |
P/OCF Ratio | 9.93 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.29, with an EV/FCF ratio of 25.89.
EV / Earnings | 28.66 |
EV / Sales | 0.84 |
EV / EBITDA | 8.29 |
EV / EBIT | 14.24 |
EV / FCF | 25.89 |
Financial Position
The company has a current ratio of 1.34, with a Debt / Equity ratio of 1.19.
Current Ratio | 1.34 |
Quick Ratio | 0.39 |
Debt / Equity | 1.19 |
Debt / EBITDA | 1.92 |
Debt / FCF | 5.94 |
Interest Coverage | 2.84 |
Financial Efficiency
Return on equity (ROE) is 18.68% and return on invested capital (ROIC) is 10.72%.
Return on Equity (ROE) | 18.68% |
Return on Assets (ROA) | 6.76% |
Return on Invested Capital (ROIC) | 10.72% |
Return on Capital Employed (ROCE) | 18.17% |
Revenue Per Employee | 104,780 |
Profits Per Employee | 3,089 |
Employee Count | 64,758 |
Asset Turnover | 1.84 |
Inventory Turnover | 3.45 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.00% in the last 52 weeks. The beta is 0.24, so Raia Drogasil's price volatility has been lower than the market average.
Beta (5Y) | 0.24 |
52-Week Price Change | -50.00% |
50-Day Moving Average | 3.31 |
200-Day Moving Average | 4.09 |
Relative Strength Index (RSI) | 31.75 |
Average Volume (20 Days) | 11,615 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Raia Drogasil had revenue of 6.94 billion and earned 204.73 million in profits. Earnings per share was 0.12.
Revenue | 6.94B |
Gross Profit | 2.05B |
Operating Income | 408.37M |
Pretax Income | 233.03M |
Net Income | 204.73M |
EBITDA | 534.53M |
EBIT | 408.37M |
Earnings Per Share (EPS) | 0.12 |
Balance Sheet
The company has 82.01 million in cash and 1.35 billion in debt, giving a net cash position of -1.26 billion.
Cash & Cash Equivalents | 82.01M |
Total Debt | 1.35B |
Net Cash | -1.26B |
Net Cash Per Share | n/a |
Equity (Book Value) | 1.13B |
Book Value Per Share | 0.66 |
Working Capital | 586.30M |
Cash Flow
In the last 12 months, operating cash flow was 462.18 million and capital expenditures -235.55 million, giving a free cash flow of 226.64 million.
Operating Cash Flow | 462.18M |
Capital Expenditures | -235.55M |
Free Cash Flow | 226.64M |
FCF Per Share | n/a |
Margins
Gross margin is 29.57%, with operating and profit margins of 5.88% and 2.95%.
Gross Margin | 29.57% |
Operating Margin | 5.88% |
Pretax Margin | 3.36% |
Profit Margin | 2.95% |
EBITDA Margin | 7.70% |
EBIT Margin | 5.88% |
FCF Margin | 3.26% |
Dividends & Yields
This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 2.25%.
Dividend Per Share | 0.05 |
Dividend Yield | 2.25% |
Dividend Growth (YoY) | 33.16% |
Years of Dividend Growth | n/a |
Payout Ratio | 40.42% |
Buyback Yield | 1.63% |
Shareholder Yield | 3.88% |
Earnings Yield | 4.46% |
FCF Yield | 4.94% |
Stock Splits
The last stock split was on October 1, 2020. It was a forward split with a ratio of 5.
Last Split Date | Oct 1, 2020 |
Split Type | Forward |
Split Ratio | 5 |
Scores
Raia Drogasil has an Altman Z-Score of 3.98.
Altman Z-Score | 3.98 |
Piotroski F-Score | n/a |